Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/042174external-prioritypatent/WO2012174061A1/fr
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of MA35168B1publicationCriticalpatent/MA35168B1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne une combinaison qui comprend : (a) composé a ((r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile) de la formule (a) :
MA36539A2011-06-142013-12-06Combinaison de panobinostat et de ruxolitinib dans le traitement du cancer tel qu'un néoplasme myéloprolifératif
MA35168B1
(fr)